Impact of Drainless Donor Abdominal Site in Deep Inferior Epigastric Perforator (DIEP) Flap on Complications and Duration of Hospital Stay.
1 other identifier
interventional
150
1 country
1
Brief Summary
Inserting surgical drains is an ancient approach used across different specialties because of its many advantages such as discharge of fluid accumulation, appraising and qualifying drain capacities, lowering infection percentages, and eliminating dead space. Most commonly, abdominal closed-suction drains are used following autologous breast reconstruction with a DIEP flap to prevent donor site complications such as seroma, hematoma, and wound dehiscence. Although abdominal drains are effective in impeding accumulation, they are a potential portal for infection, Furthermore, they restrict patient mobility, are cumbersome, require time-consuming care upon discharge, potentially increase inpatient stay and ultimately resulting in impaired health-care costs. In the context of an Enhanced Rapid Protocol (ERP), not placing abdominal drains would be a step forward. This involves using \"quilting sutures\" to close the dead space after flap prelevation. Quilting sutures are placed between the subcutaneous tissues of the abdominal flap and the underlying fascia of the rectus abdominis muscle and aim to minimizes the shearing forces and collapse the death space without the use of drains. Progressive tension sutures were first described in 2000, in a retrospective paper on cosmetic abdominoplasty patients. Since then, their procedure has been analysed and adapted by many authors and applied in perforator-based abdominal flaps for breast reconstruction. Despite the drainless approach is well known in the literature for cosmetic abdominoplasty procedures, prospective clinical investigations to encourage the drainless approach in DIEP flap reconstruction is lacking. Therefore we want to set up a prospective study to make a comparison between the outcomes succeeding donor site closure after DIEP flap harvesting with (AD) or without (W-AD) the use of abdominal drains and investigate whether there is a correlation between the use of drains and the length of hospital stay. Secondary outcomes involve the complication rate of seroma, hematoma, and dehiscence analysis of abdominal drain output and postoperative recovery, including pain and follow-up complications as described above.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 26, 2024
CompletedFirst Posted
Study publicly available on registry
June 21, 2024
CompletedStudy Start
First participant enrolled
July 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2026
CompletedJune 21, 2024
June 1, 2024
1.9 years
May 26, 2024
June 15, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Length of stay (LOS)
Length of hospital stay (LOS) is the same or less in patients without abdominal drains versus patients with drains
During admission to the hospital
Secondary Outcomes (3)
Complication rate
from enrollment until study completion, an average of 1 year
Pain (VAS)
from enrollment until study completion, an average of 1 year
Patient satisfaction (Breast Q)
from enrollment until study completion, an average of 1 year
Study Arms (2)
DIEP flap surgery with drains
ACTIVE COMPARATORPatients will undergo a breast reconstruction by a DIEP flap with drains.
DIEP flap surgery without drains
EXPERIMENTALPatients will undergo a breast reconstruction by a DIEP flap without drains.
Interventions
Patients will undergo a breast reconstruction with a DIEP flap without the placement of drains.
Patients will undergo a breast reconstruction with a DIEP flap with the placement of drains.
Eligibility Criteria
You may qualify if:
- Written informed consent must be obtained prior to any screening procedures
- Gender: female
- Age \>18 years old
- Breast cancer for which mastectomy is planned (primary case) OR patient has already had mastectomy (secondary case)
- Wish to have a DIEP flap procedure (uni-or bilateral) for breast reconstruction
- Meets criteria for DIEP flap procedure (no previous open abdominal surgery)
- Pre- and postoperative smoking cessation of 3 months
You may not qualify if:
- Patient has history of open abdominal surgery wich compromises blood flow to DIEP flap
- Any disorder, which in the investigator's opinion might jeopardise participant's safety or compliance with the CIP.
- Female who is pregnant, breast-feeding or intends to become pregnant or is of child-bearing potential and not using an adequate contraceptive method.
- No informed consent
- Age \< 18 years old
- Currently smoking or cessation \<3 months preoperatively
- The use of immunosuppressive drugs
- Other ongoing therapies which might compromise normal postoperative course (e.g. chemotherapy, radiotherapy, …)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Uz Leuven
Leuven, Vlaams-Brabant, 3000, Belgium
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Julie Paternoster, Medical doctor
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical doctor in plastic surgery
Study Record Dates
First Submitted
May 26, 2024
First Posted
June 21, 2024
Study Start
July 1, 2024
Primary Completion
June 1, 2026
Study Completion
August 1, 2026
Last Updated
June 21, 2024
Record last verified: 2024-06